相关实验视频

Updated: Jul 8, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

APOE3ch改变了微质反应,抑制了Aβ诱导的tau播种和传播

Yun Chen¹, Sihui Song², Samira Parhizkar³

¹Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

|December 12, 2023

概括

通过减少粉样β斑块和陶病理,APOE3克莱斯特彻奇突变可以预防阿尔茨海默病. 这项研究在小鼠模型中探索了它的效果,揭示了病的潜在治疗点.

科学领域:

神经科学
遗传学
病理学

背景情况:

一种罕见的APOE3克莱斯特彻奇 (APOE3ch) 突变与对自体主导阿尔茨海默病 (AD) 的抗性有关.
APOE3ch对阿尔茨海默病的保护机制,特别是它在粉样β (Aβ) 和病理中的作用,尚不清楚.

研究的目的:

在人性化小鼠模型中研究APOE3ch突变对阿尔茨海默病的功能影响.
确定APOE3ch是否影响粉样蛋白和粉样蛋白的播种和扩散,以及相关的微质反应.

主要方法:

创建了一个人性化的APOE3ch鼠标模型.
交叉APOE3ch小鼠与一个Aβ斑块沉积模型.
注射AD-tau大脑提取物以评估在粉样蛋白存在或不存在时的粉样蛋白播种和扩散.
分析了微质细胞和骨髓细胞的反应,以及APOE3ch与肝素硫酸蛋白糖的结合.

主要成果:

导致了周围脂质失调和与斑块相关的病理.
在Aβ斑块周围观察到粉样蛋白反应降低和微质激活增强.
已证明肌肉细胞细胞增生和tau聚合物的降解,与较弱的APOE3ch与肝素硫酸蛋白糖的结合有关.
通过影响对Aβ斑块的微质反应,APOE3ch抑制了Aβ诱导的tau播种和扩散.

结论:

通过调节微质反应和增强质聚合物清除,APOE3ch可保护抗Aβ诱导的病.
这些发现表明针对阿尔茨海默病和相关病的APOE3ch介导途径的新疗法.

更多相关视频

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...